Lite Strategy, Inc. (NASDAQ:LITS)
| Market Cap | 49.00M-43.3% |
| Revenue (ttm) | 0 |
| Net Income | -60.82M-92.1% |
| EPS | -1.79-92.2% |
| Shares Out | 34.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Nov 16, 2023 |
| Volume | 2,261,682 |
| Open | 1.43 |
| Previous Close | 1.43 |
| Day's Range | 1.36 - 1.53 |
| 52-Week Range | 0.69 - 2.97 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 28, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About LITS
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$LITS stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in LITS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by LITS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
LITS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
LITS Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Cash and cash equivalents | $7.54M | 84.66% |
| Asset management fee and advisory fees | $675.00K | 7.57% |
| Professional fees | $409.00K | 4.59% |
| Legal fees | $283.00K | 3.18% |
As of: Q1 2026 (Mar 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New LITS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to LITS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in LITS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $650.37K |
| VXFVanguard Extended Market ETF | $356.71K |
| IWCiShares Micro-Cap ETF | $155.02K |
Estimated from each fund’s disclosed top holdings × AUM
LITS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from LITS’s recent data — informational, not investment advice